Komar
Plasma Endothelin‐1 in patients with atrial septal defect – the novel diagnostic indicator (RCD code: IV-2B.1) Monika Komar, Jakub Podolec, Urszula Gancarczyk, Wojciech Płazak, Bartosz Sobień, Lidia Tomkiewicz‑Pająk, Piotr Wilkołek, Tadeusz Przewłocki, Piotr Podolec Full Text: PDF Abstract Background: The study aimed to assess the level of plasma Endothelin-1 (ET-1) in patients before and after transcatheter […]
Kopeć
Establishing a curriculum on rare diseases for medical students Grzegorz Kopeć, Piotr Podolec Full Text: PDF Abstract Healthcare workers often have insufficient knowledge on rare diseases that may lead to delay in making a diagnosis and providing appropriate care. The fifth area of the Europlan entitled: “Gathering The Expertise On Rare Diseases At European Level” […]
Podolec
Improving education quality in the field of rare diseases following European Union recommendations Piotr Podolec Full Text: PDF Abstract Dear Friends and Readers, This is always a pleasure to introduce the new issue of our Journal. This time we start from the article that confirms the importance of rare diseases problem – not only in terms of economy, but […]
Rubis
Report from the European Society of Cardiology Congress 2015 in London Pawel Rubis Full Text: PDF Abstract At least for us, the ESC Congress 2015 in London was different from the previous ones as we did not organize Satellite Symposium on rare cardiovascular diseases. It is not that we did not want to, on the […]
Mizia-Stec
Aortic arch aneurysm (RCD code: I-2A.O) Katarzyna Mizia-Stec, Zbigniew Gąsior, Mariusz Skowerski, Jolanta Nowak, Błażej Kusz, Maciej Tomasz Wybraniec Full Text: PDF Abstract An aortic aneurysm is defined as a pathologic dilatation to more than 1.5 times the normal diameter of the aorta. The prognosis is serious; several segments of the aorta can be dilated […]
Lenart
The 51‐year‐old patient with a non‐compaction cardiomiopathy and multi‐vessel coronary artery disease (RCD code: III-5A.1) Aleksandra Lenart, Klaudia Knap, Michał Pacia, Lidia Tomkiewicz‑Pająk, Małgorzata Urbańczyk‑Zawadzka, Robert Paweł Banyś, Maria Olszowska, Piotr Podolec Full Text: PDF Abstract Left ventricular non-compaction (LVNC) or “spongy myocardium”, is a rare form of a primary genetic cardiomyopathy considered to be […]
Siudak
Pulmonary arterial hypertension in a patient with unilateral pulmonary artery absence (RCD code: II-2A.1) Lukasz Siudak, Daria Gorczyca-Siudak, Ryszard Grzywna, Piotr Blaszczak Full Text: PDF Abstract Pulmonary artery absence is a rare congenital defect, occurring in 1 out of 100 000 individuals. In its isolated unilateral form only one in three cases concerns the left […]
Mizia-Stec
Patent ductus arteriosus recanalization following its successful surgical closure (RCD code: IV-2B.4) Katarzyna Mizia-Stec, Zbigniew Gąsior, Leszek Szymański, Wojciech Walkowicz, Magdalena Mizia, Piotr Pysz, Maciej Tomasz Wybraniec, Błażej Kusz Full Text: PDF Abstract Patent ductus arteriosus (PDA) is rarely diagnosed late in adult life, and frequently in children as an isolated disorder or complex congenital […]
Kaznica-Wiatr
Establishing the optimal dose of nitric oxide in acute vasoreactivity testing in patients with pulmonary hypertension with use of the Bronchial Control Treatment System (RCD code: II) Magdalena Kaznica-Wiatr, Maria Olszowska, Piotr Podolec Full Text: PDF Abstract The key point in the diagnostic algorithm for pulmonary hypertension plays the pulmonary reactivity testing, the agent most […]
Kopec
Combination therapy in the treatment of pulmonary arterial hypertension – 2015 update. Grzegorz Kopec, Piotr Podolec Full Text: PDF Abstract Pulmonary arterial hypertension (PAH) is a disease with a poor prognosis and high mortality rates therefore in the era of advanced therapies targeting different patophysiological pathways attractive seems the idea of combining drugs from two […]
